Swiss National Bank’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-75,200
| Closed | -$2.11M | – | 2838 |
|
|
2022
Q1 | $2.11M | Buy |
75,200
+5,600
| +8% | +$153K | ﹤0.01% | 2010 |
|
|
2021
Q4 | $1.9M | Hold |
69,600
| – | – | ﹤0.01% | 2098 |
|
|
2021
Q3 | $1.89M | Buy |
69,600
+1,100
| +2% | +$27.2K | ﹤0.01% | 2089 |
|
|
2021
Q2 | $1.17M | Buy |
68,500
+1,200
| +2% | +$22.5K | ﹤0.01% | 2416 |
|
|
2021
Q1 | $1.41M | Buy |
67,300
+900
| +1% | +$20.8K | ﹤0.01% | 2205 |
|
|
2020
Q4 | $1.52M | Hold |
66,400
| – | – | ﹤0.01% | 2068 |
|
|
2020
Q3 | $1.08M | Buy |
66,400
+3,100
| +5% | +$56.2K | ﹤0.01% | 2051 |
|
|
2020
Q2 | $857K | Buy |
63,300
+2,200
| +4% | +$25.6K | ﹤0.01% | 2194 |
|
|
2020
Q1 | $724K | Buy |
61,100
+800
| +1% | +$17.7K | ﹤0.01% | 2000 |
|
|
2019
Q4 | $1.5M | Buy |
60,300
+1,700
| +3% | +$34.5K | ﹤0.01% | 1896 |
|
|
2019
Q3 | $997K | Buy |
58,600
+1,800
| +3% | +$32.8K | ﹤0.01% | 2059 |
|
|
2019
Q2 | $1.29M | Buy |
56,800
+3,900
| +7% | +$105K | ﹤0.01% | 1974 |
|
|
2019
Q1 | $1.7M | Buy |
52,900
+1,700
| +3% | +$52.6K | ﹤0.01% | 1762 |
|
|
2018
Q4 | $1.44M | Buy |
51,200
+2,500
| +5% | +$73.2K | ﹤0.01% | 1774 |
|
|
2018
Q3 | $1.4M | Hold |
48,700
| – | – | ﹤0.01% | 1946 |
|
|
2018
Q2 | $1.82M | Buy |
48,700
+2,900
| +6% | +$114K | ﹤0.01% | 1767 |
|
|
2018
Q1 | $1.8M | Buy |
45,800
+3,000
| +7% | +$110K | ﹤0.01% | 1709 |
|
|
2017
Q4 | $1.39M | Hold |
42,800
| – | – | ﹤0.01% | 1886 |
|
|
2017
Q3 | $1.33M | Hold |
42,800
| – | – | ﹤0.01% | 1882 |
|
|
2017
Q2 | $1.2M | Buy |
42,800
+8,200
| +24% | +$186K | ﹤0.01% | 1935 |
|
|
2017
Q1 | $593K | Hold |
34,600
| – | – | ﹤0.01% | 2306 |
|
|
2016
Q4 | $419K | Hold |
34,600
| – | – | ﹤0.01% | 2450 |
|
|
2016
Q3 | $548K | Hold |
34,600
| – | – | ﹤0.01% | 2317 |
|
|
2016
Q2 | $447K | Buy |
34,600
+5,200
| +18% | +$81.4K | ﹤0.01% | 2407 |
|
|
2016
Q1 | $540K | Buy |
29,400
+5,500
| +23% | +$99.6K | ﹤0.01% | 2266 |
|
|
2015
Q4 | $538K | Hold |
23,900
| – | – | ﹤0.01% | 2219 |
|
|
2015
Q3 | $559K | Buy |
23,900
+2,900
| +14% | +$80K | ﹤0.01% | 2135 |
|
|
2015
Q2 | $601K | Buy |
+21,000
| New | +$550K | ﹤0.01% | 2125 |
|
Swiss National Bank's XENT Position: Q2 2022 in Review
Swiss National Bank sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 75,200 shares — an estimated $2.11M sold.
Swiss National Bank first reported a position in XENT in Q2 2015 and held it in 28 quarters. The position peaked at $2.11M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Swiss National Bank reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Swiss National Bank sold 75,200 Intersect ENT, Inc shares in Q2 2022, an estimated $2.11M.
- Swiss National Bank first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 28 quarters.
- Swiss National Bank's Intersect ENT, Inc position peaked at $2.11M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.